HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelin B receptor-mediated protection against anoxia-reoxygenation injury in perfused rat liver: nitric oxide-dependent and -independent mechanisms.

Abstract
This study aimed to investigate the roles of endothelin (ET) receptors in biliary dysfunction and cell injury in postischemic livers. Rat livers perfused with oxygenated Krebs-Henseleit solution were exposed to reoxygenation following 20-minute hypoxia. The anoxic perfusion decreased bile output and reduced cyclic guanosine monophosphate (cGMP) contents, an index of nitric oxide (NO) generation. Upon reoxygenation, the decreased bile was not fully recovered, and the resistance increased biphasically: an early transient spike accompanied by an elevated release of ET-1 and a rise accompanied by a cGMP elevation in the later period. The initial vasoconstriction appeared to be mediated by both ET(A) and ET(B) receptors, as judged by inhibitory effects of their antagonists, BQ-485 and BQ-788, respectively, while the late elevation of the resistance was not attenuated by these reagents, but rather enhanced by the ET(B) blockade. The BQ-788 treatment attenuated the reoxygenation-induced cGMP elevation and induced bile acid-dependent choleresis. However, such a change upon the ET(B) blockade coincided with dissociation of a recovery of phospholipids and aggravation of cell injury. The BQ-788-elicited deterioration of reoxygenation-elicited changes was attenuated by NO supplement with S-nitroso-N-acetyl penicillamine. N(omega)-Nitro-L-arginine methyl ester, an NO synthase inhibitor, mimicked biliary changes elicited by the ET(B) blockade but without causing notable cell injury. Under these circumstances, coadministration of clotrimazole, an inhibitor of cytochrome P450 mono-oxygenases, elicited the injury comparable with that observed under the ET(B) blockade. These results suggest that ET(B)-mediated signaling limits excessive bile acid excretion and plays a protective role against reoxygenation injury through mechanisms involving both NO-dependent and -independent processes.
AuthorsH Taniai, M Suematsu, T Suzuki, S Norimizu, R Hori, Y Ishimura, Y Nimura
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 33 Issue 4 Pg. 894-901 (Apr 2001) ISSN: 0270-9139 [Print] United States
PMID11283854 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Azepines
  • Bile Acids and Salts
  • Endothelin Receptor Antagonists
  • Oligopeptides
  • Piperidines
  • Receptor, Endothelin B
  • Receptors, Endothelin
  • BQ 485
  • Nitric Oxide
  • BQ 788
Topics
  • Animals
  • Azepines (pharmacology)
  • Bile (physiology)
  • Bile Acids and Salts (urine)
  • Cholestasis (etiology)
  • Endothelin Receptor Antagonists
  • Ischemia (pathology)
  • Male
  • Nitric Oxide (physiology)
  • Oligopeptides (pharmacology)
  • Perfusion
  • Piperidines (pharmacology)
  • Rats
  • Rats, Wistar
  • Receptor, Endothelin B
  • Receptors, Endothelin (physiology)
  • Renal Circulation
  • Reperfusion Injury (complications, pathology, physiopathology)
  • Vascular Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: